Introduction
Recursion combines automated biology and AI to industrially scale drug discovery. Official materials describe a platform that maps biology and generates insights for therapeutic programs.
Verified details are taken from Recursion’s official website.
What the company does
TechBio company using AI and automated experiments for drug discovery, documented on recursion.com.
Who it serves
Biopharma partners and internal pipelines for therapeutic discovery.
Company background
United States
Product and AI capabilities
TechBio company using AI and automated experiments for drug discovery, documented on recursion.com.
Key developments
Why it matters
Recursion is a public TechBio reference for AI-enabled drug discovery with an official R&D platform footprint.
Sector context
See Brel’s Healthcare sector hub for related profiles.
Sources and references
Official: https://www.recursion.com